Clinical Trial Update: Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tamoxifen citrate in metastatic or recurrent breast cancer completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen citrate (tamoxifen citrate)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Breast Cancer, Stage IV Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-03-14